Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent (R) SES with Absorbable Polymer
- Publisher: NEW YORK
Journal of the American College of Cardiology,
Cardiology and Cardiovascular Medicine
Background : The MiStent SES (Micell Technologies, Durham, NC) is an investigational drug-eluting stent (DES) developed to adress unfavorable late-term outcomes such as stent thrombosis. These events are hypothesized to be associated in part with durable polymers of cur...